Exemestane CAS 107868-30-4 Anti Estrogen Steroid Aromasin Muscle Building
Exemestane CAS 107868-30-4 Anti Estrogen Steroid Aromasin Muscle BuildingExemestaneOther name: AromasinCAS No:107868-30-4Molecular Formula: C20H24O2Assay: 99%Appearance: White or almost White Crystalline Powder.Usage:Developed to help fight breast cancer, Aromasin is one of the most powerful estrogen suppressing compounds available for body builders taking anabolic steroids. Additionally, it also raises testosterone in the body, which is a bonus for bodybuilders during post-cycle-therapy.Aromasin (Exemestane) is one of those weird compounds that nobody really knows what to do with. It’s a third generation Aromatase Inhibitor (AI) just like Arimidex (Anastrozole) and Femera (Letrozole).Payment Method: Money Gram/Western Union T/T , Bitcoin .Product description:Aromasin is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy.Treating advanced breast cancer in women who are past menopause and whose disease has progressed after treatment with other medicines. It is also used in the treatment of early breast cancer in certain women who are past menopause and after treatment with other medicines. It may also be used for other conditions as determined by your doctor.Exemestane is an aromatase inhibitor. It works by stopping the production of estrogen, which may decrease the size and growth of the tumor.Applications:AROMASIN is a prescription medicine for:Early breast cancer: AROMASIN is indicated for the adjuvant treatment (additional treatment given after the primary or main treatment) of postmenopausal women with estrogen-receptor positive (ER positive) early breast cancer. If switching to AROMASIN, treatment with AROMASIN should begin 2 to 3 years after tamoxifen, at which time tamoxifen should be stopped. Treatment with AROMASIN should continue for 2 to 3 years until a total of 5 years of adjuvant treatment of tamoxifen and AROMASIN have been completed.Advanced breast cancer: AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.Applications:Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive and can be treated with drugs that block the effects of these hormones.In women who have had their menopause, oestrogen is mainly produced by changing androgens (sex hormones produced by the adrenal glands) into oestrogens. This process is called aromatisation and happens mainly in the fatty tissues, muscle and the skin. It needs a particular enzyme called aromatase.Exemestane blocks the process of aromatisation. So it lowers the amount of oestrogen in the body. In early breast cancer, taking exemestane can help to stop breast cancer coming back. In advanced breast cancer the cancer cells may grow more slowly or stop growing completely.The median duration of adjuvant treatment was 27.4 months and 27.3 months for patients receiving AROMASIN or tamoxifen, respectively, within the IES study and 23.9 months for patients receiving AROMASIN or placebo within the 027 study. Median duration of observation after randomization for AROMASIN was 34.5 months and for tamoxifen was 34.6 months. Median duration of observation was 30 months for both groups in the 027 study.
Flugestone 17-acetate
CAS: 2529-45-5
MF: C23H31FO5
MW: 406.49
EINECS: 219-776-9
Usage A synthetic progesterone, used to induce oestrus synchronisation in goats and sheep.
Color: white powde
help
Add to favorite
Favorite products
